Donald S Fong, Aniz Girach, April Boney
Journal: Retina (Philadelphia, Pa.) 2007;27(7):816-24
PMID: 17891003
PURPOSE
To review the literature on limitations and adverse effects associated with scatter or panretinal laser photocoagulation (PRP) for diabetic retinopathy (DR).
DESIGN
Literature review.
RESULTS
Scatter laser photocoagulation is associated with moderate visual loss, some diminished visual field, reduced color vision, and reduced contrast sensitivity.
CONCLUSIONS
Scatter laser photocoagulation has been shown to reduce the risk of severe visual loss from proliferative DR. However, scatter treatment is associated with some decline in visual function. These effects should be studied more extensively and should be considered when comparing pharmacologic treatments for proliferative DR.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.